Ventricular volume and dementia progression in the Cardiovascular Health Study

Neurobiology of Aging
Owen T CarmichaelJ T Becker

Abstract

Elevated cerebral ventricular volume may be associated with dementia risk and progression. A fully-automated technique that agreed highly with radiological readings was used to estimate lateral ventricle volume on MR scans done at baseline in 1997-99 of 377 subjects in the Cardiovascular Health Study (CHS) from the Pittsburgh Center. 327 subjects were normal or diagnosed with mild cognitive impairment (MCI) at baseline and were evaluated 4 years later. Baseline ventricular volume was analyzed in multivariate models with age, gender, education level, presence and incidence of cerebral infarcts, and dementia category (normal, MCI, or dementia) at baseline and follow-up as fixed effects. Ventricular volume at baseline was significantly higher among subjects normal at baseline and demented 4 years later. Age, gender, education level, and dementia progression were significant factors affecting ventricular volume. Ventricular volume was higher in dementia compared to MCI, higher in MCI compared to controls, and higher in Possible-Alzheimer's-disease (AD) dementia compared to Probable-AD. Larger ventricles in healthy subjects may indicate susceptibility to, or progression of, dementia-related pathology.

References

May 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J D Van Horn, I C McManus
Jun 1, 1989·AJR. American Journal of Roentgenology·M J de LeonJ Cohen
Feb 24, 1998·Stroke; a Journal of Cerebral Circulation·L H KullerR Bhadelia
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J de LeonJ Fowler
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·A T DuM W Weiner
Apr 24, 2002·Neurology·R J KillianyM S Albert
Jun 1, 2002·Alzheimer Disease and Associated Disorders·Yuan-Yu HsuMichael W Weiner
Oct 23, 2002·Human Brain Mapping·Stephen M Smith
Feb 5, 2003·Neuroepidemiology·Oscar L LopezNorman Beauchamp
Feb 5, 2003·Neuroepidemiology·Lewis H KullerMary N Haan
Feb 22, 2003·NeuroImage·Gaël Chetelat, Jean-Claude Baron
Mar 28, 2003·The New England Journal of Medicine·Sarah E VermeerMonique M B Breteler
Jul 14, 2004·Neurology·Mary GanguliSteven T DeKosky
Jul 28, 2004·NeuroImage·Paul M ThompsonArthur W Toga
Oct 13, 2004·Archives of Neurology·Niels D PrinsMonique M B Breteler
May 11, 2005·Neurology·T R StoubL deToledo-Morrell
Jul 12, 2005·Neurobiology of Aging·Kristine B WalhovdBruce Fischl
Aug 1, 2006·Neurobiology of Aging·Owen T CarmichaelJ T Becker

❮ Previous
Next ❯

Citations

Dec 1, 2012·Journal of Neural Transmission·C AnnweilerUNKNOWN WALK Team-Working group Angers-London for Knowledge
Jun 30, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Liana G Apostolova, Paul M Thompson
Oct 30, 2009·Psychological Medicine·B SchmandW A van Gool
Aug 2, 2008·Brain : a Journal of Neurology·Sean M NestorUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 6, 2007·Alzheimer Disease and Associated Disorders·Owen T CarmichaelJames T Becker
Feb 22, 2012·Alzheimer Disease and Associated Disorders·Liana G ApostolovaPaul M Thompson
Apr 5, 2012·Epilepsia·Kevin DabbsBruce Hermann
Jul 21, 2009·European Radiology·Jasper D SluimerFrederik Barkhof
May 1, 2008·The British Journal of Radiology·P M Thompson, L G Apostolova
Jun 28, 2014·Experimental Gerontology·Cedric AnnweilerOlivier Beauchet
Jul 14, 2010·Neurobiology of Aging·Yi-Yu ChouUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 27, 2008·Psychiatry Research·Christine N VidalPaul M Thompson
Jul 18, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Andrew M HallJames T Becker
Jan 3, 2013·Molecular Nutrition & Food Research·Cédric AnnweilerOlivier Beauchet
May 4, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Liana G ApostolovaPaul M Thompson
Aug 1, 2006·Neurobiology of Aging·Owen T CarmichaelJ T Becker
Oct 15, 2014·Neurobiology of Aging·Sarah K MadsenUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Oct 1, 2015·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Obulesu MagisettyShamasundar N Mannar
Jan 15, 2014·Neurobiology of Aging·Florence F RoussotteUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Jan 9, 2013·NeuroImage·Boris A GutmanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 3, 2010·Neurobiology of Aging·Owen CarmichaelCharles Decarli
Aug 5, 2011·Neurobiology of Aging·Liana ApostolovaMona K Beyer
Mar 2, 2011·NeuroImage·Martha SkupUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 29, 2011·NeuroImage·Yalin WangUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 7, 2014·NeuroImage·Jie ShiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 22, 2010·Neurobiology of Aging·Alasdair M J MacLullichJonathan R Seckl
Aug 22, 2013·Journal of Neurodevelopmental Disorders·Diane MullinsDeclan G Murphy
Aug 21, 2019·Brain Structure & Function·Lachlan T StrikeMargaret J Wright
Mar 10, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Cláudia Y SantosJessica Alber
May 25, 2018·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Özlem KirazlıSafiye Çavdar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.